AcuCort

is a Sweden-based clinical-stage biopharmaceutical company that provides develops and commercializes Zeqmelit for inflammation, autoimmune diseases, and cancer...
Read more

AcuCort

is a Sweden-based clinical-stage biopharmaceutical company that provides develops and commercializes Zeqmelit for inflammation, autoimmune diseases, and cancer...
Read more
AcuCort CEO: Jonas Jonmark

CEO

Jonas Jonmark

CEO Approval Rating

- -/100

2011

PrivateIndependent Company

Add Industry
Add Sector
Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Contacts
New
Schedule a Demo

AcuCort News

AcuCort Press Releases

AcuCort Headquarters

Kullagatan 8

Helsingborg, Skåne länSE-252 20

Driving Directions »

AcuCort Summary

ABOUT

Overview

AcuCort is a Sweden-based clinical-stage biopharmaceutical company that provides develops and commercializes Zeqmelit for inflammation, autoimmune diseases, and cancer. AcuCort was founded in 2011. AcuCort's headquarters is located in Helsingborg, Skå...

Website

acucort.se

Competitors

There are no competitors identified for AcuCort

Acquisitions

There have been no acquisitions found related to AcuCort

Funding

Funding data cannot be found related to AcuCort

Investments

Recent investment data cannot be found related to AcuCort

Frequently Asked Questions about AcuCort

  1. When was AcuCort founded?

    AcuCort was founded in 2011
  2. Who is AcuCort's CEO?

    AcuCort's CEO is Jonas Jonmark
  3. How much revenue does AcuCort generate?

    AcuCort generates $ < 1M in revenue
  1. How much funding does AcuCort have?

    AcuCort has historically raised $0 in funding
  2. Where is AcuCort's headquarters?

    AcuCort's headquarters is in Helsingborg Skåne län, SE
  3. How many employees does AcuCort have?

    AcuCort has 0 employees

Trending Companies